New WHO advice on biosimilar medicines aims to increase access to quality treatment
First in vitro diagnostic prequalified through the alternative performance evaluation mechanism
WHO launches five-year plan to improve the quality and safety of health products
Lymphatic filariasis: 465 million treatments delivered through expanded coverage, combined medicines
Kiribati eliminates lymphatic filariasis
Medical Product Alert N° 3/2019: Falsified ICLUSIG (Asia and globally)
Messages for World Leprosy Day 2020
Despite challenges, Yemen eliminates lymphatic filariasis
